Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Previous close
¥24.96
Day range
¥24.50 - ¥25.33
Year range
¥9.44 - ¥34.68
Market cap
9.72B CNY
Avg Volume
7.30M
P/E ratio
163.94
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 218.36M | 40.44% |
Operating expense | 180.63M | 22.08% |
Net income | 20.27M | 1,139.49% |
Net profit margin | 9.28 | 842.40% |
Earnings per share | — | — |
EBITDA | 31.04M | 138.11% |
Effective tax rate | 6.69% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 201.92M | -31.72% |
Total assets | 1.84B | 10.34% |
Total liabilities | 901.81M | 16.87% |
Total equity | 934.42M | — |
Shares outstanding | 405.93M | — |
Price to book | 10.95 | — |
Return on assets | 3.20% | — |
Return on capital | 4.37% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 20.27M | 1,139.49% |
Cash from operations | 3.77M | -50.22% |
Cash from investing | -15.77M | 84.42% |
Cash from financing | 4.85M | -86.55% |
Net change in cash | -7.16M | 87.57% |
Free cash flow | -5.30M | 90.22% |
About
Founded
Dec 11, 2009
Website
Employees
463
